Literature DB >> 31709779

2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures.

Bryant R England1, Benedict K Tiong2, Martin J Bergman3, Jeffrey R Curtis4, Salahuddin Kazi5, Ted R Mikuls1, James R O'Dell1, Veena K Ranganath2, Alex Limanni6, Lisa G Suter7, Kaleb Michaud8.   

Abstract

OBJECTIVE: To provide updated American College of Rheumatology (ACR) recommendations on rheumatoid arthritis (RA) disease activity measurements to facilitate a treat-to-target approach in routine clinical care.
METHODS: A working group conducted a systematic literature review from the time of the prior ACR recommendations literature search. Properties of disease activity measures were abstracted, and study quality was assessed using the Consensus-Based Standards for the selection of Health Measurement Instruments 4-point scoring method, allowing for overall level of evidence assessment. Measures that fulfilled a minimum standard were identified, and through a modified Delphi process preferred measures were selected for regular use in most clinic settings.
RESULTS: The search identified 5,199 articles, of which 110 were included in the review. This search identified 46 RA disease activity measures that contained patient, provider, laboratory, and/or imaging data. Descriptions of the measures, properties, study quality, level of evidence, and feasibility were abstracted and scored. Following a modified Delphi process, 11 measures fulfilled a minimum standard for regular use in most clinic settings, and 5 measures were recommended: the Disease Activity Score in 28 Joints with Erythrocyte Sedimentation Rate or C-Reactive Protein Level, Clinical Disease Activity Index, Simplified Disease Activity Index, Routine Assessment of Patient Index Data 3, and Patient Activity Scale-II.
CONCLUSION: We have updated prior ACR recommendations for preferred RA disease activity measures, identifying 11 measures that met a minimum standard for regular use and 5 measures that were preferred for regular use in most clinic settings.
© 2019, American College of Rheumatology.

Entities:  

Mesh:

Year:  2019        PMID: 31709779      PMCID: PMC6884664          DOI: 10.1002/acr.24042

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  21 in total

1.  Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire.

Authors:  Frederick Wolfe; Kaleb Michaud; Theodore Pincus
Journal:  Arthritis Rheum       Date:  2004-10

2.  The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2010-07       Impact factor: 6.437

Review 3.  Measurement properties of rheumatoid arthritis-specific quality-of-life questionnaires: systematic review of the literature.

Authors:  Jiyeon Lee; Soo Hyun Kim; Seung Hei Moon; Eun-Hyun Lee
Journal:  Qual Life Res       Date:  2014-05-21       Impact factor: 4.147

4.  Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.

Authors:  Marije F Bakker; Johannes W G Jacobs; Aike A Kruize; Maaike J van der Veen; Catharina van Booma-Frankfort; Simone A Vreugdenhil; Johannes W J Bijlsma; Floris P J G Lafeber; Paco M J Welsing
Journal:  Ann Rheum Dis       Date:  2011-11-29       Impact factor: 19.103

5.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2010-02-19       Impact factor: 4.147

Review 6.  Measurement properties of outcome measures for vitiligo. A systematic review.

Authors:  Charlotte Vrijman; May W Linthorst Homan; Jacqueline Limpens; Wietze van der Veen; Albert Wolkerstorfer; Caroline B Terwee; Phyllis I Spuls
Journal:  Arch Dermatol       Date:  2012-11

7.  Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.

Authors:  Aline Ranzolin; João Carlos Tavares Brenol; Markus Bredemeier; Jairo Guarienti; Marcele Rizzatti; Daniel Feldman; Ricardo Machado Xavier
Journal:  Arthritis Rheum       Date:  2009-06-15

8.  Change of psychological distress and physical disability in patients with rheumatoid arthritis over the last two decades.

Authors:  Cécile L Overman; Maud S Jurgens; Ercolie R Bossema; Johannes W G Jacobs; Johannes W J Bijlsma; Rinie Geenen
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-05       Impact factor: 4.794

9.  Measurement of patient outcome in arthritis.

Authors:  J F Fries; P Spitz; R G Kraines; H R Holman
Journal:  Arthritis Rheum       Date:  1980-02

10.  Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis.

Authors:  Jos Hendrikx; Marieke J de Jonge; Jaap Fransen; Wietske Kievit; Piet Lcm van Riel
Journal:  RMD Open       Date:  2016-08-18
View more
  43 in total

1.  2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis.

Authors:  Claire E H Barber; JoAnn Zell; Jinoos Yazdany; Aileen M Davis; Laura Cappelli; Linda Ehrlich-Jones; Donna Everix; J Carter Thorne; Victoria Bohm; Lisa Suter; Alex Limanni; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-11       Impact factor: 4.794

2.  Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.

Authors:  Silje Watterdal Syversen; Guro Løvik Goll; Kristin Kaasen Jørgensen; Øystein Sandanger; Joseph Sexton; Inge Christoffer Olsen; Johanna Elin Gehin; David John Warren; Marthe Kirkesæther Brun; Rolf Anton Klaasen; Lars Normann Karlsen; Geir Noraberg; Camilla Zettel; Maud Kristine Aga Ljoså; Anne Julsrud Haugen; Rune Johan Njålla; Trude Jannecke Bruun; Kathrine Aglen Seeberg; Brigitte Michelsen; Eldri Kveine Strand; Svanaug Skorpe; Ingrid Marianne Blomgren; Yngvill Hovde Bragnes; Christian Kvikne Dotterud; Turid Thune; Carl Magnus Ystrøm; Roald Torp; Pawel Mielnik; Cato Mørk; Tore K Kvien; Jørgen Jahnsen; Nils Bolstad; Espen A Haavardsholm
Journal:  JAMA       Date:  2021-05-04       Impact factor: 56.272

3.  Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort.

Authors:  Katherine D Wysham; Jane Shofer; Gabriella Lui; Laura Trupin; James S Andrews; Dennis M Black; Jonathan Graf; Dolores M Shoback; Patricia P Katz
Journal:  Semin Arthritis Rheum       Date:  2022-01-31       Impact factor: 5.532

4.  Prevalence of Common Comorbidities in Rheumatoid Arthritis in Rural New York Compared With National Data.

Authors:  Daniel T Fuller; Eyal Kedar; Carly R Lovelett; Sumona Mondal; Shantanu Sur
Journal:  Cureus       Date:  2021-11-10

5.  The beneficial effect of baricitinib on ultrasound-detected synovial inflammation and bone damage in rheumatoid arthritis: Preliminarily data from single center-based observational study for 24 weeks.

Authors:  Seong-Kyu Kim; Ui Hong Jung; Ji-Won Kim; Jung-Yoon Choe
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

Review 6.  Measuring Outcomes in Psoriatic Arthritis.

Authors:  Alexis Ogdie; Laura C Coates; Philip Mease
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

7.  Association of Disease Activity and Disability With Rehabilitation Utilization in African American Adults With Rheumatoid Arthritis.

Authors:  Louise M Thoma; Rebecca J Cleveland; Beth L Jonas; S Louis Bridges; Leigh F Callahan
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01       Impact factor: 4.794

8.  2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Authors:  Liana Fraenkel; Joan M Bathon; Bryant R England; E William St Clair; Thurayya Arayssi; Kristine Carandang; Kevin D Deane; Mark Genovese; Kent Kwas Huston; Gail Kerr; Joel Kremer; Mary C Nakamura; Linda A Russell; Jasvinder A Singh; Benjamin J Smith; Jeffrey A Sparks; Shilpa Venkatachalam; Michael E Weinblatt; Mounir Al-Gibbawi; Joshua F Baker; Kamil E Barbour; Jennifer L Barton; Laura Cappelli; Fatimah Chamseddine; Michael George; Sindhu R Johnson; Lara Kahale; Basil S Karam; Assem M Khamis; Iris Navarro-Millán; Reza Mirza; Pascale Schwab; Namrata Singh; Marat Turgunbaev; Amy S Turner; Sally Yaacoub; Elie A Akl
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-06-08       Impact factor: 5.178

9.  Predictive ability, validity, and responsiveness of the multi-biomarker disease activity score in patients with rheumatoid arthritis initiating methotrexate.

Authors:  Brent A Luedders; Tate M Johnson; Harlan Sayles; Geoffrey M Thiele; Ted R Mikuls; James R O'Dell; Bryant R England
Journal:  Semin Arthritis Rheum       Date:  2020-06-17       Impact factor: 5.532

10.  Quantifying Potential Cost-Savings Through an Alternative Imaging-Based Diagnostic Process in Presumptive Seronegative Rheumatoid Arthritis.

Authors:  Pedro Santos-Moreno; Nelson J Alvis-Zakzuk; Edwin Castillo; Laura Villarreal; Carlos Pineda; Hugo Sandoval; Omaira Valencia
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.